Uncategorized

La pregunta es inquietante por el aumento de la población mundial y por el avance del cambio climático global. En una investigación reciente, se ha encontrado una respuesta.   Unos investigadores del Instituto de Análisis Económico (IAE) del Consejo Superior …

High-level turnover has introduced uncertainty about how quickly the FDA’s agency-wide AI strategy will move forward.

Many employers are considering the coverage arrangements, but confidence in the ACA marketplaces — including potentially high costs for workers — are making them hesitant to move forward, according to a survey.

Challenges in the electrophysiology and Watchman businesses led the medtech company to cut its sales and earnings per share forecasts for the second quarter in a row.

Facing competition from Edwards, Abbott is studying TriClip’s real-world safety and performance in about 1,000 patients.

Biogen officially began reporting revenue from the $5.6 billion acquisition of Apellis in the second quarter, shaking up analysts’ consensus estimates and leading to a beat.

Looking for a biopharma job in New York? Check out the BioSpace list of seven companies hiring life sciences professionals like you.

Business stage is just one factor in whether biopharmas want job candidates to have oncology experience for oncology roles. Two recruiters explain when oncology expertise matters most, the mistakes job seekers make and how to make a good impression.

ElevateBio will be the primary source of Kyverna’s autologous CAR-T cell therapy for anticipated U.S. and global launches in autoimmune indications.

Shareholders allege that Novo Nordisk withheld information about crucial protocol changes in a Phase 3 study of the weight loss drug CagriSema, which led investors to buy company shares “at artificially inflated prices.”